Loading...
Loading...
India's empagliflozin imports from VIETNAM total $115 across 1 shipments from 1 foreign suppliers. DR. REDDYS LABORATORIES LIMITED leads with $115 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin โ a concentrated sourcing relationship with select suppliers from VIETNAM.

DR. REDDYS LABORATORIES LIMITED is the leading Empagliflozin supplier from VIETNAM to India, with import value of $115 across 1 shipments. The top 5 suppliers โ DR. REDDYS LABORATORIES LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR. REDDYS LABORATORIES LIMITED | $115 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LIMITED | $115 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Empagliflozin suppliers from VIETNAM to India include DR. REDDYS LABORATORIES LIMITED. The leading supplier is DR. REDDYS LABORATORIES LIMITED with import value of $115 USD across 1 shipments. India imported Empagliflozin worth $115 USD from VIETNAM in total across 1 shipments.
India imported Empagliflozin worth $115 USD from VIETNAM across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Empagliflozin sourced from VIETNAM include DR.REDDY'S LABORATORIES LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LIMITED with $115 in imports across 1 shipments.
The total value of Empagliflozin imports from VIETNAM to India is $115 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists